Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the safety and effectiveness of an herbal product for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more
NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more
NCT06810180 · Attention Deficit Hyperactivity Disorder (ADHD), Sleep, and more
NCT07189442 · Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD)
NCT06325813 · Attention Deficit Hyperactivity Disorder
Bastyr University
Kenmore, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions